ARTICLE | Company News
Parker Institute, PsiOxus to test virus-based cancer immunotherapies
November 30, 2018 8:32 PM UTC
PsiOxus Therapeutics Ltd. (Abingdon, U.K.) partnered with the Parker Institute for Cancer Immunotherapy to conduct preclinical research of PsiOxus’ IV virus-based gene therapy to treat solid tumors. The partners will build and test viruses carrying different combinations of genes...